| Analysis of the toxicity of gold nano particles on the immune system: effect on dendritic cell functions CL Villiers, H Freitas, R Couderc, MB Villiers, PN Marche Journal of Nanoparticle Research 12, 55-60, 2010 | 270 | 2010 |
| Toward a better analysis of secreted proteins: the example of the myeloid cells secretome M Chevallet, H Diemer, A Van Dorssealer, C Villiers, T Rabilloud Proteomics 7 (11), 1757-1770, 2007 | 199 | 2007 |
| Interaction of 125I-labelled complement subcomponents C1r and C1s with protease inhibitors in plasma RB Sim, A Reboul, GJ Arlaud, CL Villiers, MG Colomb FEBS letters 97 (1), 111-115, 1979 | 188 | 1979 |
| A Top‐Down synthesis route to ultrasmall multifunctional Gd‐Based silica nanoparticles for theranostic applications A Mignot, C Truillet, F Lux, L Sancey, C Louis, F Denat, F Boschetti, ... Chemistry–A European Journal 19 (19), 6122-6136, 2013 | 162 | 2013 |
| Electronic sorting and recovery of single live cells from microlitre sized samples AB Fuchs, A Romani, D Freida, G Medoro, M Abonnenc, L Altomare, ... Lab on a Chip 6 (1), 121-126, 2006 | 130 | 2006 |
| Human endogenous retrovirus protein activates innate immunity and promotes experimental allergic encephalomyelitis in mice H Perron, HL Dougier-Reynaud, C Lomparski, I Popa, R Firouzi, ... PloS one 8 (12), e80128, 2013 | 123 | 2013 |
| Predictive Toxicology of cobalt ferrite nanoparticles: comparative in-vitro study of different cellular models using methods of knowledge discovery from data L Horev-Azaria, G Baldi, D Beno, D Bonacchi, U Golla-Schindler, ... Particle and fibre toxicology 10, 1-17, 2013 | 120 | 2013 |
| Predictive Toxicology of Cobalt Nanoparticles and Ions: Comparative In Vitro Study of Different Cellular Models Using Methods of Knowledge Discovery from Data L Horev-Azaria, CJ Kirkpatrick, R Korenstein, PN Marche, O Maimon, ... Toxicological Sciences 122 (2), 489-501, 2011 | 115 | 2011 |
| From secretome analysis to immunology: chitosan induces major alterations in the activation of dendritic cells via a TLR4-dependent mechanism C Villiers, M Chevallet, H Diemer, R Couderc, H Freitas, A Van Dorsselaer, ... Molecular & cellular proteomics 8 (6), 1252-1264, 2009 | 107 | 2009 |
| Purified proenzyme C1r. Some characteristics of its activation and subsequent proteolytic cleavage GJ Arlaud, CL Villiers, S Chesne, MG Colomb Biochimica et Biophysica Acta (BBA)-Enzymology 616 (1), 116-129, 1980 | 105 | 1980 |
| Impact of silica nanoparticle surface chemistry on protein corona formation and consequential interactions with biological cells A Kurtz-Chalot, C Villiers, J Pourchez, D Boudard, M Martini, PN Marche, ... Materials Science and Engineering: C 75, 16-24, 2017 | 103 | 2017 |
| Domain structure and associated functions of subcomponents C1r and C1s of the first component of human complement. CL Villiers, GJ Arlaud, MG Colomb Proceedings of the National Academy of Sciences 82 (13), 4477-4481, 1985 | 99 | 1985 |
| Clinically related protein–peptide interactions monitored in real time on novel peptide chips by surface plasmon resonance imaging B Cherif, A Roget, CL Villiers, R Calemczuk, V Leroy, PN Marche, ... Clinical Chemistry 52 (2), 255-262, 2006 | 90 | 2006 |
| Cryptic O2–-generating NADPH oxidase in dendritic cells S Elsen, J Doussière, CL Villiers, M Faure, R Berthier, A Papaioannou, ... Journal of cell science 117 (11), 2215-2226, 2004 | 78 | 2004 |
| Proteolysis of C3 on U937 cell plasma membranes. Purification of cathepsin G. CM Maison, CL Villiers, MG Colomb Journal of immunology (Baltimore, Md.: 1950) 147 (3), 921-926, 1991 | 72 | 1991 |
| Adenine nucleotide transport in sonic submitochondrial particles. Kinetic properties and binding of specific inhibitors GJM Lauquin, C Villiers, JW Michejda, LV Hryniewiecka, PV Vignais Biochimica et Biophysica Acta (BBA)-Bioenergetics 460 (2), 331-345, 1977 | 65 | 1977 |
| Tailoring nanostructured lipid carriers for the delivery of protein antigens: Physicochemical properties versus immunogenicity studies T Courant, E Bayon, HL Reynaud-Dougier, C Villiers, M Menneteau, ... Biomaterials 136, 29-42, 2017 | 61 | 2017 |
| Molecular characterization of the catalytic domains of human complement serine protease C. hivin. 1r GJ Arlaud, J Gagnon, CL Villiers, MG Colomb Biochemistry 25 (18), 5177-5182, 1986 | 61 | 1986 |
| Fluid-phase interaction of C1 inhibitor (C1 Inh) and the subcomponents C1r and C1s of the first component of complement, C1 S Chesne, CL Villiers, GJ Arlaud, MB Lacroix, MG Colomb Biochemical Journal 201 (1), 61-70, 1982 | 59 | 1982 |
| C1q binding and complement activation by prions and amyloids RB Sim, U Kishore, CL Villiers, PN Marche, DA Mitchell Immunobiology 212 (4-5), 355-362, 2007 | 57 | 2007 |
